Vocalis Health CEO Tal Wenderow on Vocal Biomarkers, Healthcare, and Coronavirus - Voicebot Podcast Ep 145

Tal Wanderow is CEO of Vocalis. He and host Bret Kinsella discuss
the latest progress behind employing vocal biomarkers to evaluate
health conditions and risks. We go into detail about the current
work behind tools for diagnosing and monitoring COVID-19
patients. We even explore the ethics of what data patients should
have a right to access.


Vocalis Health is focused on using vocal biomarkers to identify
the likelihood of hospitalization for a variety of conditions and
have another product focused on respiratory disease detection and
monitoring. Given that background, it’s not surprising that the
company has taken a prominent role in the healthcare industry
response to the coronavirus pandemic.